Eating With Eosinophilic Esophagitis (EoE)

Status Completed

Clinical Trial Summary

Is there a difference in the eating process for patients with active Eosinophilic Esophagitis (EoE) and those with inactive disease?

Clinical Trial Description

Eosinophilic esophagitis (EoE) patients develop adapted eating behaviors to prevent symptoms. These patients tend to cut their food small, chew extensively, take copious liquids with meals, and avoid foods that cause symptoms. No studies to date have directly evaluated these eating behaviors in patients with EoE with observation. Furthermore, none of the investigators' current metrics for patient symptom assessment visually evaluate the eating process nor are they compared before and after treatment. As a result, it is unclear if a patient's subjective perception of their eating difficulties and improvement matches with objective measures. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03581838
Study type	Observational
Source	Mayo Clinic
Contact
Status	Completed
Phase
Start date	May 24, 2018
Completion date	July 23, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04394351` - Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)	Phase 3
Terminated	`NCT03245840` - Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)	Phase 3
Completed	`NCT02778867` - SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study	Phase 2/Phase 3
Completed	`NCT01642212` - OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension	Phase 2
Completed	`NCT05485779` - SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects	Phase 1
Recruiting	`NCT04626609` - Prostaglandin and Cannabinoid Receptors in EoE
Completed	`NCT00762073` - Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis	Phase 2
Terminated	`NCT02058537` - Bethanechol for Eosinophilic Esophagitis	Phase 2
Completed	`NCT02605837` - A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved	Phase 3
Completed	`NCT02320981` - Mucosal Impedance in Pediatric Population	N/A
Recruiting	`NCT06389994` - Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Completed	`NCT02736409` - An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)	Phase 3